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Introduction
R ecurrent hypoglycemia may impair brain function and child development, later on. Long-term sequelae of severe hypoglycemia were recurrent seizure and mental retardation. Permanent defect of the brain may develop after hypoglycemia 1 . Perinatal stress including neonatal asphyxia is one of important cause of hypoglycemia 2, 3 . Neonatal asphyxia is related to excessive glycogenolysis leading to the decrease of glycogen storage. Continuously high insulin release due to asphyxia causing extreme fatigue and damage in b-cell of pancreas. This condition often results in hypoglycemia 4 . Capacity of a newborn in maintaining glucose homeostasis is limited due to metabolic transition 5 . Nowadays, early diagnosis and treatment of neonatal hypoglycemia is considered to be the best choice in preventing further brain damage 4 . Therefore, identifying preventable risk factors minimizes the negative impacts of neonatal hypoglycemia on the child's growth and development.
The aims of this study were to identify the risk factors of neonatal hypoglycemia and its related variables, focusing on the role of asphyxia in neonatal hypoglycemia.
Material and Methods
A nested case-control study using WHO -South East Asia Regional Neonatal-Perinatal Database was conducted at Maternal Perinatal Unit, Dr. Sardjito General Hospital, Yogyakarta from January until December 2013. Newborn with and without hypoglycemia who admitted into Perinatal ward or Neonatal Intensive Care Unit at Dr. Sardjito General hospital were considered as research subject.
Newborns without any major congenital anomaly were further classifi ed into case and control group. Neonatal hypoglycemia was confi rmed if the blood glucose levels <45 mg/dL. Neonates diagnosed with hypoglycemia were then classifi ed into the case group, and those who weren't, into the control group. The subject will be included in the case group if hypoglycemia were diagnosed and major congenital anomalies were not found. Those who were in the control group did not experience hypoglycemia and any major congenital anomalies. The exclusion criterias were incomplete data, neonates weighing 500 grams or less at birth, or left against medical advice.
The diagnosis of asphyxia was made if the neonate's one-minute APGAR score was ≤7 22 . We included in the analysis 14 confounders, namely multiple fetus, large for gestational age, small for gestational age, premature rupture of the membrane, prematurity, low birth weight, early onset neonatal sepsis, placenta previa, Caesarean section, pre-eclampsia or eclampsia, respiratory distress syndrome, congenital heart disease, meconium aspiration syndrome, and maternal diabetes.
Sample size was calculated with statistical power=0.8, a=0.05, proportion of hypoglycemia among asphyxiated newborn=0.3 6 , and proportion of hypoglycemia among non-asphyxiated newborn=14% 7, 8 . 
Results
A total of 1562 live births were recruited to this study ( Figure 1 ). Five hundreds and twenty (33,3%) were excluded due to major congenital anomalies and incomplete data. There were 234 (22.5%) newborns with hypoglycemia and 385 (36.9%) newborns with asphyxia. By using simple randomization methods, we had 52 newborns with hypoglycemia on case group and 104 newborns without hypoglycemia on control group. Baseline characteristics of the newborns in the two groups are shown in Table 1 . Overall, the mean birth weight and gestational age of newborns with hypoglycemia was lower compared to newborns without hypoglycemia (2283.4 g vs. 2788.0 g; 35.7 vs. 37.7 weeks, respectively). All deliveries were attended by doctors. Apgar score <7 were more commonly found in newborns with hypoglycemia than those without hypoglycemia (52% vs. 31.8%).
The results of the bivariate and multivariate analysis for hypoglycemia risk factors are shown in Table  2 . Placenta previa, premature rupture of membrane, congenital heart disease, and infants of diabetic mothers were not included into bivariate analysis because the number of the subjects were too small. Asphyxia, LBW, SGA, LGA, prematurity, pre-eclampsia/ eclampsia, meconium aspiration syndrome, RDS, and early onset neonatal sepsis had P value <0.2 and thus were included into multivariate analysis model. The multivariate analysis result showed that asphyxia, LBW, LGA, and early onset neonatal sepsis were signifi cant risk factors for neonatal hypoglycemia.
Discussion
Our study demonstrated that mean plasma glucose level was lower in newborns with asphyxia. Other studies reported similar results 3, 9 . Basu et al., reported that the severity of asphyxia was directly proportional to the degree of hypoglycemia 3 . Our study also indicated that higher proportion of hypoglycemia were found among newborns diagnosed with asphyxia (67.3% vs 32.7%).
J. Nepal Paediatr. Soc. Asphyxia as a risk factor for neonatal hypoglycemia was also reported by other researchers. However, the magnitude of that risk was not indicated in the previous study 10 . Hypoglycemia caused by asphyxia can be explained by several mechanisms. During asphyxia, anaerobe glycolysis process results in the production of 2 molecules of adenosine triphosphate (ATP) from each molecule of glucose, instead of 38 ATP which usually were produced during aerobic condition. Anaerobic glycolysis elevates lactic acid production. Severe acidosis, on the other hand, diminishes glycolysis, causes loss of cardiovascular autoregulation, and decreases cardiac function. Furthermore, this process results in local ischemia and limitation in glucose transportation 3 . The unexplained catecholamine release and hyperinsulinemia will decrease glycogen storage 9 . Newborn with asphyxia demonstrates higher blood insulin levels within fi rst 24 and 72 hours of life, which potentially suppress hepatic glycogenolysis response 11 . Besides that, hypoxia of the brain increases glucose consumption. Compared with adult brain, an immature brain of low birth weight infant is more resistant to injury caused by hypoxia. Moreover, combined hypoglycemia and asphyxia results in the failure of compensatory mechanism to save the brain from damage due to persistent hypoxia 3 .
Male infants in our study experienced more hypoglycemia and asphyxia compared to female. Other study supported our result, and the researchers argued that hormonal system of male infants were less likely to be more mature than females'. There was also reported that they had such different enzymatic responses towards ketogenesis 12 .
Low birth weight as a risk factor of hypoglycemia is also reported by other studies. De et al. demonstrated higher hypoglycemia prevalence among low birth weight infants compared to normal birth weight newborn. Moreover, mean of blood glucose levels of low birth weight infants were lower than normal weight infants at 1, 6, 12, and 24 hour(s) after birth 13 . Other study reported a high prevalence (52%) of hypoglycemia among low birth weight infant and newborn with birth weight less than 10 th percentile 14 . In order to maintain the normoglycemic condition, newborn needs suffi cient glycogen storage, maturation of glycogenolytic and gluconeogenic pathway, as well as integration of endocrine response. The increase of adrenalin secretion and rapid decrease of insulin-glucagon ratio within the fi rst hour of life, stimulate glucose release and fat metabolism from peripheral storage 13 .
The study result from Esakof et al. supported ours. Newborns with birth weight ≥4000 g had higher risk of getting hypoglycemia compared with those whose birth weight <4000 g. Maternal gestational diabetes increased the risk of LGA. The incidence of hypoglycemia within fi rst hour of life was more common in neonates born from mothers with gestational diabetes 16 . Several extrinsic factors infl uencing birth weight were smoking mother, viral infection, diabetes and hypertension. Other factors such as maternal height, BMI, weight gain during pregnancy may also infl uence it. Genetic factor and excessive nutrient intake may exaggerate infant growth 16 .
LGA infants form non-diabetic mothers may experience transient hypoglycemia, especially those whose mothers are obese. However, the mechanism is still unclear. It is likely that hyperinsulinism is not a major factor 5 .
Our study demonstrated that early onset of neonatal sepsis was also a risk factor of neonatal hypoglycemia. Campos et al. reported that 99% of newborn with sepsis had abnormal blood glucose levels, 58% of them were hypoglycemic 17 . Neonatal sepsis infl uences blood glucose levels through several mechanisms. Newborns presenting with sepsis experience feeding diffi culties, increase of metabolic demands, and hypothermia 18 . Moreover, sepsis correlates with the increase metabolic rate and risk of toxic effect on liver metabolism, which then results in hypoglycemia 4 .
The risk of hypoglycemia among premature infants as seen in our study can be explained through several reasons. Premature infant has minimal brown fat compared to the mature infants, immature central nerve system, delayed response on hypercarbia, hypotonia of the upper respiratory muscles, less energy storage, and immature mechanism of glucose regulation 19 . The delay of glucose-6-phosphate activity results in abnormality of glycogenolysis and gluconeogenesis response. Minimal oral or enteral intake due to weakness of sucking and swallowing refl exes and immaturity of gastrointestinal system are other problems which may increase the risk 20 .
The role of prematurity as a signifi cant risk factor which showed in bivariate analysis was not further proved in multivariate analysis. We argue that 80.8% of premature infants in our study were low birth weight. Therefore, risk of prematurity on neonatal hypoglycemia actually refl ects the risk of low birth weight itself. In our study, low birth weight increases risk for neonatal hypoglycemia by 7.1 times compared with normal birth weight.
One of our study limitation is the application of Apgar score to defi ne asphyxia rather than blood gas analysis. Using only Apgar score as diagnosis criteria of asphyxia raised a controversy. Apgar score ≥7 usually indicates a rigorous condition 21 predicting infants' future health status, instead of confi rming asphyxia. The type of congenital heart disease that had been registered was only patent ductus arteriosus. The data did not refl ect the spectrum of congenital heart disease. The timing of blood sampling for detection of hypoglycemia was not recorded. Consequently, no exact time of the occurrence of hypoglycemia was available. The number of subjects with placenta previa, premature rupture of the membrane, meconium aspiration syndrome, RDS, congenital heart disease, and maternal diabetes were small which raises the possibility of unrepresentative results.
However, our study has a strength. We analyzed 14 potential confounders. The residual confounders in our study is unlikely to be found. Therefore, the role of asphyxia as a risk factor for neonatal hypoglycemia as seen in our study is a strong evidence. The signifi cant relationship between confounders, i.e. LBW, LGA, and early onset of neonatal sepsis and neonatal hypoglycemia indicates that these confounders are also signifi cant risk factors for neonatal hypoglycemia.
Conclusion
Asphyxia is a risk factor for neonatal hypoglycemia, as well as LBW, LGA and early onset of neonatal sepsis.
